vs
Side-by-side financial comparison of Dexcom (DXCM) and GUESS INC (GES). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $791.4M, roughly 1.6× GUESS INC). Dexcom runs the higher net margin — 21.2% vs 3.2%, a 18.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 7.2%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -5.8%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Guess?, Inc. is an American clothing company, notable for its black-and-white advertisements. It licenses its brand on other fashion accessories, such as watches, jewelry, perfumes, bags and shoes.
DXCM vs GES — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $791.4M |
| Net Profit | $267.3M | $25.6M |
| Gross Margin | 62.9% | 42.5% |
| Operating Margin | 25.6% | 2.9% |
| Net Margin | 21.2% | 3.2% |
| Revenue YoY | 21.6% | 7.2% |
| Net Profit YoY | 153.6% | 209.6% |
| EPS (diluted) | $0.67 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $791.4M | ||
| Q3 25 | $1.2B | $772.9M | ||
| Q2 25 | $1.2B | $647.8M | ||
| Q1 25 | $1.0B | $932.3M | ||
| Q4 24 | $1.1B | $738.5M | ||
| Q3 24 | $994.2M | $732.6M | ||
| Q2 24 | $1.0B | $591.9M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $25.6M | ||
| Q3 25 | $283.8M | $6.2M | ||
| Q2 25 | $179.8M | $-32.9M | ||
| Q1 25 | $105.4M | $81.4M | ||
| Q4 24 | $151.7M | $-23.4M | ||
| Q3 24 | $134.6M | $-10.6M | ||
| Q2 24 | $143.5M | $13.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 42.5% | ||
| Q3 25 | 60.5% | 42.5% | ||
| Q2 25 | 59.5% | 39.9% | ||
| Q1 25 | 56.9% | 44.1% | ||
| Q4 24 | 58.9% | 43.6% | ||
| Q3 24 | 59.7% | 43.7% | ||
| Q2 24 | 62.4% | 41.9% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 2.9% | ||
| Q3 25 | 20.1% | 2.3% | ||
| Q2 25 | 18.4% | -5.1% | ||
| Q1 25 | 12.9% | 11.1% | ||
| Q4 24 | 17.0% | 5.7% | ||
| Q3 24 | 15.3% | 6.5% | ||
| Q2 24 | 15.7% | -3.4% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 3.2% | ||
| Q3 25 | 23.5% | 0.8% | ||
| Q2 25 | 15.5% | -5.1% | ||
| Q1 25 | 10.2% | 8.7% | ||
| Q4 24 | 13.6% | -3.2% | ||
| Q3 24 | 13.5% | -1.4% | ||
| Q2 24 | 14.3% | 2.2% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.48 | ||
| Q3 25 | $0.70 | $0.12 | ||
| Q2 25 | $0.45 | $-0.65 | ||
| Q1 25 | $0.27 | $1.29 | ||
| Q4 24 | $0.37 | $-0.47 | ||
| Q3 24 | $0.34 | $-0.28 | ||
| Q2 24 | $0.35 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $154.2M |
| Total DebtLower is stronger | — | $299.5M |
| Stockholders' EquityBook value | $2.7B | $508.5M |
| Total Assets | $6.3B | $3.0B |
| Debt / EquityLower = less leverage | — | 0.59× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $154.2M | ||
| Q3 25 | $1.8B | $189.6M | ||
| Q2 25 | $1.2B | $151.2M | ||
| Q1 25 | $904.9M | $187.7M | ||
| Q4 24 | $606.1M | $140.9M | ||
| Q3 24 | $621.2M | $218.9M | ||
| Q2 24 | $939.2M | $241.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $299.5M | ||
| Q3 25 | — | $258.4M | ||
| Q2 25 | — | $241.7M | ||
| Q1 25 | — | $150.7M | ||
| Q4 24 | — | $238.3M | ||
| Q3 24 | — | $187.8M | ||
| Q2 24 | — | $196.9M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $508.5M | ||
| Q3 25 | $2.7B | $487.6M | ||
| Q2 25 | $2.6B | $483.6M | ||
| Q1 25 | $2.3B | $505.0M | ||
| Q4 24 | $2.1B | $450.7M | ||
| Q3 24 | $2.0B | $491.2M | ||
| Q2 24 | $2.4B | $565.5M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.0B | ||
| Q3 25 | $7.5B | $3.0B | ||
| Q2 25 | $7.3B | $2.9B | ||
| Q1 25 | $6.8B | $2.8B | ||
| Q4 24 | $6.5B | $2.8B | ||
| Q3 24 | $6.4B | $2.8B | ||
| Q2 24 | $6.8B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.59× | ||
| Q3 25 | — | 0.53× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.38× | ||
| Q2 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-39.5M |
| Free Cash FlowOCF − Capex | — | $-56.3M |
| FCF MarginFCF / Revenue | — | -7.1% |
| Capex IntensityCapex / Revenue | — | 2.1% |
| Cash ConversionOCF / Net Profit | — | -1.54× |
| TTM Free Cash FlowTrailing 4 quarters | — | $62.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $-39.5M | ||
| Q3 25 | $659.9M | $74.9M | ||
| Q2 25 | $303.0M | $-73.4M | ||
| Q1 25 | $183.8M | $183.2M | ||
| Q4 24 | $301.4M | $-83.3M | ||
| Q3 24 | $199.5M | $44.7M | ||
| Q2 24 | $279.4M | $-22.9M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-56.3M | ||
| Q3 25 | $579.4M | $53.4M | ||
| Q2 25 | $208.9M | $-95.3M | ||
| Q1 25 | $96.8M | $160.7M | ||
| Q4 24 | $176.8M | $-105.4M | ||
| Q3 24 | $88.3M | $24.3M | ||
| Q2 24 | $213.3M | $-44.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -7.1% | ||
| Q3 25 | 47.9% | 6.9% | ||
| Q2 25 | 18.1% | -14.7% | ||
| Q1 25 | 9.3% | 17.2% | ||
| Q4 24 | 15.9% | -14.3% | ||
| Q3 24 | 8.9% | 3.3% | ||
| Q2 24 | 21.2% | -7.4% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 2.1% | ||
| Q3 25 | 6.7% | 2.8% | ||
| Q2 25 | 8.1% | 3.4% | ||
| Q1 25 | 8.4% | 2.4% | ||
| Q4 24 | 11.2% | 3.0% | ||
| Q3 24 | 11.2% | 2.8% | ||
| Q2 24 | 6.6% | 3.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | -1.54× | ||
| Q3 25 | 2.33× | 12.00× | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | 2.25× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | -1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
GES
| Products | $760.3M | 96% |
| Royalty | $31.1M | 4% |
